Prokidney (PROK) Construction in Progress (2021 - 2026)
Prokidney's (PROK) quarterly Construction in Progress came in at $21.7 million in Q2 2026, up 378.63% year-over-year from $4.5 million in Q2 2025, and up 12.29% quarter-over-quarter from $19.3 million in Q1 2026.
Analysis
Prokidney (PROK) Construction in Progress (2021 - 2026) Analysis & Trends
Prokidney (PROK) has reported Construction in Progress for 6 consecutive years, with $21.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Construction in Progress rose 378.63% year-over-year to $21.7 million in Q2 2026; TTM through Jun 2026 was $21.7 million, a 378.63% increase from a year earlier, with the FY2025 full-year figure at $14.7 million, up 500.94% from the prior year.
- Construction in Progress was $21.7 million for Q2 2026 at Prokidney, up from $19.3 million in the prior quarter.
- Over five years, Construction in Progress peaked at $21.7 million in Q2 2026 and troughed at $1.0 million in Q3 2022.
- A 5-year average of $7.5 million and a median of $5.2 million in 2023 frame the typical range for Construction in Progress.
- Across the five-year window, Construction in Progress soared 746.16% in 2023 and plunged 79.64% in 2024, its largest moves.
- Over 5 years, Construction in Progress stood at $1.6 million in 2022, then surged by 441.57% to $8.7 million in 2023, then tumbled by 72.01% to $2.4 million in 2024, then surged by 500.94% to $14.7 million in 2025, then surged by 47.58% to $21.7 million in 2026.
- The last three Construction in Progress figures came in at $21.7 million (Q2 2026), $19.3 million (Q1 2026), and $14.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 328,000.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | - |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - | 21.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.70 Mn |
| Mar 31, 2026 | 19.33 Mn |
| Dec 31, 2025 | 14.71 Mn |
| Sep 30, 2025 | 10.17 Mn |
| Jun 30, 2025 | 4.53 Mn |
| Mar 31, 2025 | 3.73 Mn |
| Dec 31, 2024 | 2.45 Mn |
| Sep 30, 2024 | 3.56 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | 9.08 Mn |
| Dec 31, 2023 | 8.74 Mn |
| Sep 30, 2023 | 8.49 Mn |
| Jun 30, 2023 | 5.86 Mn |
| Mar 31, 2023 | 3.24 Mn |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Dec 31, 2021 | 351,000.00 |